Incanthera PLC

AQSE:INC (UK) Ā  Ordinary Shares
Ā£ 0.05 (0%) Dec 24
At Loss
Market Cap:
Ā£ 4.84M ($ 6.18M)
Enterprise V:
Ā£ 4.78M ($ 6.10M)
Volume:
21.00K
Avg Vol (2M):
418.39K
Trade In:

Business Description

Incanthera PLC

ISIN : GB00BGL7YW15

Share Class Description:

AQSE:INC: Ordinary Shares
Description
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and developsĀ solutions to current clinical, commercially relevant unmet needs, utilising new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.31
Equity-to-Asset -3.4
Debt-to-Equity -0.35
Debt-to-EBITDA -0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -8.7
3-Year EPS without NRI Growth Rate -8.7
3-Year FCF Growth Rate 5.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 40.65
9-Day RSI 43.55
14-Day RSI 44.08
6-1 Month Momentum % -28.95
12-1 Month Momentum % 114.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.14
Quick Ratio 0.14
Cash Ratio 0.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.5
Shareholder Yield % -3.55

Profitability Rank

Name Current Vs Industry Vs History
ROA % -885.69
ROIC % -591.97
ROC (Joel Greenblatt) % -88440

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -3.24
EV-to-EBITDA -3.24
EV-to-FCF -32.35
Earnings Yield (Greenblatt) % -30.89
FCF Yield % -17.31

Financials

AQSE:INC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return % Ā 

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return % Ā 

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Incanthera PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil Ā£)
EPS (TTM) (Ā£) -0.019
Beta 0.23
Volatility % 136.9
14-Day RSI 44.08
14-Day ATR (Ā£) 0.033562
20-Day SMA (Ā£) 0.073175
12-1 Month Momentum % 114.29
52-Week Range (Ā£) 0.02 - 0.3125
Shares Outstanding (Mil) 92.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Incanthera PLC Filings

Filing Date Document Date Form
No Filing Data

Incanthera PLC Stock Events

Financials Calendars
Event Date Price(Ā£)
No Event Data

Incanthera PLC Frequently Asked Questions

What is Incanthera PLC(AQSE:INC)'s stock price today?
The current price of AQSE:INC is Ā£0.05. The 52 week high of AQSE:INC is Ā£0.31 and 52 week low is Ā£0.02.
When is next earnings date of Incanthera PLC(AQSE:INC)?
The next earnings date of Incanthera PLC(AQSE:INC) is .
Does Incanthera PLC(AQSE:INC) pay dividends? If so, how much?
Incanthera PLC(AQSE:INC) does not pay dividend.

Press Release

Subject Date
No Press Release